Endogenous S-nitrosothiols protect against myocardial injury

B Lima, GKW Lam, L Xie, DL Diesen… - Proceedings of the …, 2009 - National Acad Sciences
B Lima, GKW Lam, L Xie, DL Diesen, N Villamizar, J Nienaber, E Messina, D Bowles
Proceedings of the National Academy of Sciences, 2009National Acad Sciences
Despite substantial evidence that nitric oxide (NO) and/or endogenous S-nitrosothiols
(SNOs) exert protective effects in a variety of cardiovascular diseases, the molecular details
are largely unknown. Here we show that following left coronary artery ligation, mice with a
targeted deletion of the S-nitrosoglutathione reductase gene (GSNOR−/−) have reduced
myocardial infarct size, preserved ventricular systolic and diastolic function, and maintained
tissue oxygenation. These profound physiological effects are associated with increases in …
Despite substantial evidence that nitric oxide (NO) and/or endogenous S-nitrosothiols (SNOs) exert protective effects in a variety of cardiovascular diseases, the molecular details are largely unknown. Here we show that following left coronary artery ligation, mice with a targeted deletion of the S-nitrosoglutathione reductase gene (GSNOR−/−) have reduced myocardial infarct size, preserved ventricular systolic and diastolic function, and maintained tissue oxygenation. These profound physiological effects are associated with increases in myocardial capillary density and S-nitrosylation of the transcription factor hypoxia inducible factor-1α (HIF-1α) under normoxic conditions. We further show that S-nitrosylated HIF-1α binds to the vascular endothelial growth factor (VEGF) gene, thus identifying a role for GSNO in angiogenesis and myocardial protection. These results suggest innovative approaches to modulate angiogenesis and preserve cardiac function.
National Acad Sciences